Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

697 ARTÍCULOS , VIENDO DEL 436 AL 450

Perivascular space enlargement accelerates in ageing and Alzheimer's disease pathology: evidence from a three-year longitudinal multicentre study

Menze I, Bernal J, Kaya P, Aki Ç, Pfister M, Geisendörfer J, Yakupov R, Coello RD, Valdés-Hernández MDC, Heneka MT, Brosseron F, Schmid MC, Glanz W, Incesoy EI, Butryn M, Rostamzadeh A, Meiberth D, Peters O, Preis L, Lammerding D, Gref D, Priller J, Spruth EJ, Altenstein S, Lohse A, Hetzer S, Schneider A, Fliessbach K, Kimmich O, Vogt IR, Wiltfang J, Bartels C, Schott BH, Hansen N, Dechent P, Buerger K, Janowitz D, Perneczky R, Rauchmann BS, Teipel S, Kilimann I, Goerss D, Laske C, Munk MH, Sanzenbacher C, Hinderer P, Scheffler K, Spottke A, Roy-Kluth N, Lüsebrink F, Neumann K, Wardlaw J, Jessen F, Schreiber S, Düzel E, Ziegler G.

Alzheimers Res Ther. 2024 Oct 31;16(1):242. doi: 10.1186/s13195-024-01603-8.

The role of exercise in the prevention and treatment of Alzheimer's disease and mild cognitive impairments

Brooks CD, Krishnamoorthy RR, Sumien N.

Ageing Res Rev. 2024 Dec;102:102555. doi: 10.1016/j.arr.2024.102555. Epub 2024 Oct 28.

Comparative accuracy of Mini-Linguistic State Examination, Addenbrooke's Cognitive Examination, and Depistage Cognitif de Quebec for the diagnosis of primary progressive aphasia

Fernández-Romero L, Morello-García F, Laforce R Jr, Delgado-Alonso C, Delgado-Álvarez A, Gil-Moreno MJ, Lavoie M, Matias-Guiu J, Cuetos F, Matias-Guiu JA.

J Alzheimers Dis. 2024 Nov;102(1):67-76. doi: 10.1177/13872877241284199. Epub 2024 Oct 17.

Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment

Lim AWY, Schneider L, Loy C.

Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.

A comprehensive evaluation on the associations between hearing and vision impairments and risk of all-cause and cause-specific dementia: results from cohort study, meta-analysis and Mendelian randomization study

Jiang F, Dong Q, Wu S, Liu X, Dayimu A, Liu Y, Ji H, Wang L, Liu T, Li N, Li X, Fu P, Jing Q, Zhou C, Li H, Xu L, Chen S, Wang H.

BMC Med. 2024 Nov 7;22(1):518. doi: 10.1186/s12916-024-03748-7.

Enhancing guidelines for managing cognitively impaired drivers: Insights from Western evidence for Asian adaptation

Chan ML, Lim DW, Win KK, Smith H.

Ann Acad Med Singap. 2024 Oct 3;53(10):621-626. doi: 10.47102/annals-acadmedsg.2024141.

Informing cognitively healthy research participants of modifiable dementia risk factors: Ethical implications

Graham M, Rossor M, Lawlor B, Naci L.

J Alzheimers Dis. 2024 Dec;102(4):891-896. doi: 10.1177/13872877241292370. Epub 2024 Nov 8.

Emerging trends in cognitive impairment and dementia among older populations in Asia: A systematic review

Islam B, Li T, Xu M, Yang D, Lv H, Gassara G, Ibrahim TI, Radman BA, Wang J.

J Glob Health. 2024 Nov 8;14:04233. doi: 10.7189/jogh.14.04233.

Dysregulation of Noradrenergic Activity: Its Role in Conceptualizing and Treating Major Depressive Disorder, Schizophrenia, Agitation in Alzheimer's Disease, and Posttraumatic Stress Disorder

Jain R, Chepke C, Davis LL, McIntyre RS, Raskind MA.

J Clin Psychiatry. 2024 Nov 8;85(4):plunaro2417ah. doi: 10.4088/JCP.plunaro2417ah.

Dementia

Oh ES.

Ann Intern Med. 2024 Nov;177(11):ITC161-ITC176. doi: 10.7326/ANNALS-24-02207. Epub 2024 Nov 12.

Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial

Behl S, Slomkowski M, Chen D, Chang D, Hefting N, Lee D, Shah A, Estilo A, Kalu U, Hobart M.

J Alzheimers Dis. 2024 Nov;102(2):520-529. doi: 10.3233/JAD-240491. Epub 2024 Nov 13.

Cognitive reserve against Alzheimer's pathology is linked to brain activity during memory formation

Vockert N, Machts J, Kleineidam L, Nemali A, Incesoy EI, Bernal J, Schütze H, Yakupov R, Peters O, Gref D, Schneider LS, Preis L, Priller J, Spruth EJ, Altenstein S, Schneider A, Fliessbach K, Wiltfang J, Rostamzadeh A, Glanz W, Teipel S, Kilimann I, Goerss D, Laske C, Munk MH, Spottke A, Roy N, Heneka MT, Brosseron F, Wagner M, Wolfsgruber S, Dobisch L, Dechent P, Hetzer S, Scheffler K, Zeidman P, Stern Y, Schott BH, Jessen F, Düzel E, Maass A, Ziegler G; DELCODE study group.

Nat Commun. 2024 Nov 13;15(1):9815. doi: 10.1038/s41467-024-53360-9.

The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment

Fabrizi E, Ancidoni A, Locuratolo N, Piscopo P, Della Gatta F, Salemme S, Pani SM, Marconi D, Vignatelli L, Sagliocca L, Caffarra P, Secreto P, Guaita A, Stracciari A, Vanacore N, Lacorte E; Guideline Working Group.

Age Ageing. 2024 Nov 1;53(11):afae250. doi: 10.1093/ageing/afae250.

A Review of Dextromethorphan-Quinidine for the Treatment of Agitation in Dementia

Khan AN, Murphy KS, Tampi RR.

Prim Care Companion CNS Disord. 2024 Nov 14;26(6):24nr03737. doi: 10.4088/PCC.24nr03737.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias